Sort
21,453 grants matching “tuberculosis”
TB Diagnostics at the Point of Care
$999,998Christopher Gerard Cooney · Akonni Biosystems, Inc. · R44 · FY2019 · AI
New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cytometry
$999,998Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2021 · AI
Rapid Molecular Detection of Tuberculosis without PCR amplification
$999,998Alfredo Andres Celedon · Scanogen, Inc. · R44 · FY2019 · AI
A new class of antibiotic to address Antimicrobial Resistance
$999,997Charles Testa · Curza Inc · R44 · FY2025 · AI
Teixobactin Development for Tuberculosis
$999,995Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2022 · AI
Development of peptide nucleic acid antibiotics
$999,985Dev Priya Arya · Nubad, Llc · R42 · FY2021 · AI
Novel spectinamide antibiotics for the treatment of MDR/XDR tuberculosis
$999,980Michelle M. Butler · Microbiotix, Inc · R44 · FY2014 · AI
Teixobactin Development for Anthrax
$999,978Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2020 · AI
Ototoxicity of modified aminoglycosides
$999,976Sandra Paige Story · Nubad, Llc · R44 · FY2023 · AI
Ototoxicity of modified aminoglycosides
$999,975Sandra Paige Story · Nubad, Llc · R44 · FY2024 · AI
Lab-on-a-Film Multiplexed Test for Respiratory Mycobacterial Infections
$999,739Christopher Gerard Cooney · Akonni Biosystems, Inc. · R44 · FY2022 · AI
Immune Regulation in Mycobacterial and Fungal Infections
$999,676Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Drug Discovery from Slow Growing and Rare Microbial Species
$999,651Amy Lynn Spoering · Novobiotic Pharmaceuticals, Llc · R44 · FY2013 · AI
Development of a Dual-Targeting ClpP Activating Antibiotic
$999,619Michael Lafleur · Arietis · R44 · FY2024 · AI
Preclinical development of teixobactin, a new antibiotic
$999,567Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2020 · AI
Novel Spectinamide Antibiotics for the Treatment of MDR/XDR Tuberculosis
$999,559Michelle M. Butler · Microbiotix, Inc · R44 · FY2019 · AI
Development of peptide nucleic acid antibiotics
$999,557Dev Priya Arya · Nubad, Llc · R42 · FY2023 · AI
Lab-on-a-Film Multiplexed Test for Respiratory Mycobacterial Infections
$999,394Christopher Gerard Cooney · Akonni Biosystems, Inc. · R44 · FY2023 · AI
WFUSM Macaca fascicularis SPF Breeding Colony
$999,315Janice D. Wagner · Wake Forest University Health Sciences · P40 · FY2008 · RR
Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection
$999,300Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2022 · AI
Development of Coccidioides Cytokine Release Assay
$999,212Eric Holbrook · Miravista Diagnostics, Llc · R44 · FY2023 · AI
Tb-FISH (Fluorescent in Situ Hybridization) Assay for Direct Detection of M. tube
$999,123Jyotsna S Shah · Id Fish Technology, Inc. · R44 · FY2009 · AI
Preclinical development of teixobactin, a new antibiotic
$999,040Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2018 · AI
Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation
$998,606William R Clarke · Xlock Biosciences, Llc · R44 · FY2023 · AR
Development of peptide nucleic acid antibiotics
$998,585Dev Priya Arya · Nubad, Llc · R42 · FY2024 · AI